It is well documented in the literature that myocardial revascularization during valve surgery increases the risk of early mortality and morbidity. According to the most recent version of the European Guidelines, the possibility of myocardial revascularization via coronary artery bypass should be evaluated in patients with an indication for surgical treatment of heart valve disease but with coronary artery stenosis ≥ 50-70%. In this study, patients hospitalized for surgical heart valve disease, with occasional pre-operative finding of ≥ 50-70% coronary artery stenosis, without angina, are examined. After interdisciplinary discussion in the Heart Team, it was decided not to treat coronary artery disease during valve surgery. The aim is to evaluate the short and medium-term results of this "conscious omission".
Study Type
OBSERVATIONAL
Enrollment
77
Any kind of intervention on heart valves
IRCCS Ospedale San Raffaele - Cardiac Surgery Department
Milan, Italy
Survival
Time frame: through study completion, a minimum of 18 months
Percutaneous revascularization risk
Time frame: through study completion, a minimum of 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.